Canonical: https://ownershiptrace.com/13f/companies/2464

# Who owns Caris Life Sciences, Inc. (CAI)? Elite investor 13F holders

5 tracked elite investors reported holding Caris Life Sciences, Inc as of 2026-06-30, including Duquesne Family Office, Gotham Asset Management, Renaissance Technologies LLC, D.E. Shaw, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Duquesne Family Office](https://ownershiptrace.com/13f/investors/30) | Caris Life Sciences Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 33759000.00 USD | 1894450.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/1536411/0001536411-26-000006-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | Caris Life Sciences Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1595514.00 USD | 89535.000000 | Shares | reduce | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | Caris Life Sciences Inc | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 10121760.00 USD | 568000.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | Caris Life Sciences Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3649857.00 USD | 204818.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | Caris Life Sciences Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1787827.00 USD | 100327.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |
| [Ancora Advisors / Ancora Holdings](https://ownershiptrace.com/13f/investors/101) | Caris Life Sciences Inc | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1446114/0001446114-26-000012-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)